Curcumin Loaded Nanocarriers with Varying Charges Augmented with Electroporation Designed for Colon Cancer Therapy

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2022 Feb 15

PMID 35163301

Authors

Julita Kulbacka

Kazimiera A Wilk

Urszula Bazylinska

Magda Dubinska-Magiera

Stanislaw Potoczek

Jolanta Saczko

Affiliations

Soon will be listed here.

Abstract

(1) Background: The size and surface charge are the most significant parameters of nanocarriers that determine their efficiency and potential application. The poor cell uptake of encapsulated drugs is the main limitation in anticancer treatment. The well-defined properties of nanocarriers will enable to target specific tissue and deliver an active cargo. (2) Methods: In the current study, poly(D,L -lactide) (PLA) nanocarriers loaded with curcumin (CUR) and differing surface charge were evaluated for transport efficacy in combination with electroporation (EP) in dependence on the type of cells. The obtained CUR-loaded nanoparticles with diameters ranging from 195 to 334 nm (derived from dynamic light scattering (DLS)) were characterized by atomic force microscopy (AFM) (morphology and shape) and Doppler electrophoresis (-potential) as well as UV-vis spectroscopy (CUR encapsulation efficiency (about 90%) and photobleaching rate). The drug delivery properties of the obtained PLA nanocarriers enhanced by electroporation were assessed in human colon cancer cells (LoVo), excitable normal rat muscle cells (L6), and free of voltage-gated ion channels cells (CHO-K1). CLSM studies, viability, and ROS release were performed to determine the biological effects of nanocarriers. (3) Results: The highest photodynamic activity indicated anionic nanocarriers (1a) stabilized by C(COONa) surfactant. Nanocarriers were cytotoxic for LoVo cells and less cytotoxic for normal cells. ROS release increased in cancer cells with the increasing electric field intensity, irradiation, and time after EP. Muscle L6 cells were less sensitive to electric pulses. (4) Conclusions: EP stimulation for CUR-PLA nanocarriers transport was considered to improve the regulated and more effective delivery of nanosystems differing in surface charge.

Citing Articles

Curcumin inhibits the proliferation and migration of osteosarcoma by regulating the expression of superenhancerassociated genes.

Ouyang Z, Zhu H, Liu Z, Tu C, Qu J, Lu Q Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024; 49(4):541-552.

PMID: 39019783 PMC: 11255199. DOI: 10.11817/j.issn.1672-7347.2024.230224.

The Fabrication of Polymer-Based Curcumin-Loaded Formulation as a Drug Delivery System: An Updated Review from 2017 to the Present.

Azad A, Lai J, Sulaiman W, Almoustafa H, Alshehade S, Kumarasamy V Pharmaceutics. 2024; 16(2).

PMID: 38399221 PMC: 10892401. DOI: 10.3390/pharmaceutics16020160.

Field-Deployable Treatments For Leishmaniasis: Intrinsic Challenges, Recent Developments and Next Steps.

Pacheco-Fernandez T, Markle H, Verma C, Huston R, Gannavaram S, Nakhasi H Res Rep Trop Med. 2023; 14:61-85.

PMID: 37492219 PMC: 10364832. DOI: 10.2147/RRTM.S392606.

Therapeutic Applications of Curcumin and Derivatives in Colorectal Cancer.

Lambring C, Varga K, Livingston K, Lorusso N, Dudhia A, Basha R Onco Ther. 2023; 9(1):51-62.

PMID: 37324055 PMC: 10262216. DOI: 10.1615/OncoTherap.2022044575.

Use of stimulatory responsive soft nanoparticles for intracellular drug delivery.

Hughes K, Misra B, Maghareh M, Bobbala S Nano Res. 2023; 16(5):6974-6990.

PMID: 36685637 PMC: 9840428. DOI: 10.1007/s12274-022-5267-5.

References

Bisht S, Feldmann G, Soni S, Ravi R, Karikar C, Maitra A . Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy. J Nanobiotechnology. 2007; 5:3. PMC: 1868037. DOI: 10.1186/1477-3155-5-3. View

Lopresti A . The Problem of Curcumin and Its Bioavailability: Could Its Gastrointestinal Influence Contribute to Its Overall Health-Enhancing Effects?. Adv Nutr. 2018; 9(1):41-50. PMC: 6333932. DOI: 10.1093/advances/nmx011. View

Ramasamy T, Ayob A, Myint H, Thiagarajah S, Amini F . Targeting colorectal cancer stem cells using curcumin and curcumin analogues: insights into the mechanism of the therapeutic efficacy. Cancer Cell Int. 2015; 15:96. PMC: 4599442. DOI: 10.1186/s12935-015-0241-x. View

Bazylinska U, Skrzela R, Piotrowski M, Szczepanowicz K, Warszynski P, Wilk K . Influence of dicephalic ionic surfactant interactions with oppositely charged polyelectrolyte upon the in vitro dye release from oil core nanocapsules. Bioelectrochemistry. 2011; 87:147-53. DOI: 10.1016/j.bioelechem.2011.10.006. View

Shakibaei M, Mobasheri A, Lueders C, Busch F, Shayan P, Goel A . Curcumin enhances the effect of chemotherapy against colorectal cancer cells by inhibition of NF-κB and Src protein kinase signaling pathways. PLoS One. 2013; 8(2):e57218. PMC: 3579779. DOI: 10.1371/journal.pone.0057218. View

Yang X, Li Z, Wang N, Li L, Song L, He T . Curcumin-encapsulated polymeric micelles suppress the development of colon cancer in vitro and in vivo. Sci Rep. 2015; 5:10322. PMC: 4434844. DOI: 10.1038/srep10322. View

Przystupski D, Niemczura M, Gorska A, Supplitt S, Kotowski K, Wawryka P . In Search of Panacea-Review of Recent Studies Concerning Nature-Derived Anticancer Agents. Nutrients. 2019; 11(6). PMC: 6627480. DOI: 10.3390/nu11061426. View

Kulbacka J, Rembialkowska N, Szewczyk A, Moreira H, Szyjka A, Girkontaite I . The Impact of Extracellular Ca and Nanosecond Electric Pulses on Sensitive and Drug-Resistant Human Breast and Colon Cancer Cells. Cancers (Basel). 2021; 13(13). PMC: 8268418. DOI: 10.3390/cancers13133216. View

Yi G, Hong S, Son J, Yoo J, Park C, Choi Y . Recent advances in nanoparticle carriers for photodynamic therapy. Quant Imaging Med Surg. 2018; 8(4):433-443. PMC: 5989095. DOI: 10.21037/qims.2018.05.04. View

10.

Daraba O, Cadinoiu A, Rata D, Atanase L, Vochita G . Antitumoral Drug-Loaded Biocompatible Polymeric Nanoparticles Obtained by Non-Aqueous Emulsion Polymerization. Polymers (Basel). 2020; 12(5). PMC: 7284542. DOI: 10.3390/polym12051018. View

11.

Pricci M, Girardi B, Giorgio F, Losurdo G, Ierardi E, Di Leo A . Curcumin and Colorectal Cancer: From Basic to Clinical Evidences. Int J Mol Sci. 2020; 21(7). PMC: 7178200. DOI: 10.3390/ijms21072364. View

12.

Ailioaie L, Ailioaie C, Litscher G . Latest Innovations and Nanotechnologies with Curcumin as a Nature-Inspired Photosensitizer Applied in the Photodynamic Therapy of Cancer. Pharmaceutics. 2021; 13(10). PMC: 8539945. DOI: 10.3390/pharmaceutics13101562. View

13.

Mansouri K, Rasoulpoor S, Daneshkhah A, Abolfathi S, Salari N, Mohammadi M . Clinical effects of curcumin in enhancing cancer therapy: A systematic review. BMC Cancer. 2020; 20(1):791. PMC: 7446227. DOI: 10.1186/s12885-020-07256-8. View

14.

Al-Ani L, Kadir F, Hashim N, Julkapli N, Seyfoddin A, Lu J . The impact of curcumin-graphene based nanoformulation on cellular interaction and redox-activated apoptosis: An colon cancer study. Heliyon. 2020; 6(11):e05360. PMC: 7609448. DOI: 10.1016/j.heliyon.2020.e05360. View

15.

Mbese Z, Khwaza V, Aderibigbe B . Curcumin and Its Derivatives as Potential Therapeutic Agents in Prostate, Colon and Breast Cancers. Molecules. 2019; 24(23). PMC: 6930580. DOI: 10.3390/molecules24234386. View

16.

Hussain Y, Islam L, Khan H, Filosa R, Aschner M, Javed S . Curcumin-cisplatin chemotherapy: A novel strategy in promoting chemotherapy efficacy and reducing side effects. Phytother Res. 2021; 35(12):6514-6529. DOI: 10.1002/ptr.7225. View

17.

Carethers J . Systemic treatment of advanced colorectal cancer: tailoring therapy to the tumor. Therap Adv Gastroenterol. 2010; 1(1):33-42. PMC: 3002487. DOI: 10.1177/1756283X08093607. View

18.

Kielbik A, Wawryka P, Przystupski D, Rossowska J, Szewczyk A, Saczko J . Effects of Photosensitization of Curcumin in Human Glioblastoma Multiforme Cells. In Vivo. 2019; 33(6):1857-1864. PMC: 6899084. DOI: 10.21873/invivo.11679. View

19.

Toden S, Goel A . The Holy Grail of Curcumin and its Efficacy in Various Diseases: Is Bioavailability Truly a Big Concern?. J Restor Med. 2019; 6(1):27-36. PMC: 6424351. DOI: 10.14200/jrm.2017.6.0101. View

20.

Bazylinska U, Frackowiak R, Brzozka Z, Wilk K . The effect of anionic dicephalic surfactants on fabrication of varied-core nanocarriers for sustained release of porphyrin photosensitizers. J Photochem Photobiol B. 2016; 166:169-179. DOI: 10.1016/j.jphotobiol.2016.11.012. View